| Framingham Risk Score parameters |
LVEF% |
WMSI |
EDV,mL |
ESV,mL |
Infarct size core, % |
Infarct size
peri, % |
Infarct size
total, % |
Trans-mural extent |
| Male sex |
p=0.13 |
p=0.27 |
p=0.000 |
p=0.000 |
p=0.28 |
p=0.48 |
p=0.34 |
p=0.26 |
| Age |
r=-0.25; p=0.23 |
r=0.10; p=0.63 |
r=0.16; p=0.45 |
r=0.22; p=0.29 |
r=-0.13; p=0.55 |
r=-0.11; p=0.60 |
r=-0.13; p=0.55 |
r=-0.19; p=0.36 |
| Total cholesterol |
r=-0.29; p=0.16 |
r=0.17; p=0.41 |
r=0.14; p=0.50 |
r=0.20; p=0.34 |
r=-0.13; p=0.54 |
r=0.16; p=0.45 |
r=0.16; p=0.45 |
r=0.26; p=0.20 |
| HDL-cholesterol, mmol/l |
r=-0.07; p=0.73 |
r=0.18; p=0.38 |
r=-0.11; p=0.60 |
r=-0.04; p=0.84 |
r=-0.10; p=0.96 |
r=-0.02; p=0.92 |
r=-0.02; p=0.94 |
r=-0.06; p=0.77 |
| Systolic blood pressure, mmHg
Diabetes Mellitus |
r=-0.19; p=0.36
p=0.73 |
r=0.20; p=0.33
p=0.59 |
r=0.20; p=0.35
p=0.91 |
r=0.20; p=0.35
p=0.99 |
r=-0.33; p=0.53
p=0.41 |
r=-0.22; p=0.30
p=0.37 |
r=-0.19; p=0.36
p=0.36 |
r=-0.13; p=0.55
p=0.96 |
| Current smoking |
p=0.58 |
p=0.76 |
p=0.77 |
p=0.56 |
p=0.10 |
p=0.09 |
p=0.09 |
p=0.04 |
| LV hypertrophy on ECG |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
|
Table 2: Correlations between individual risk factors versus parameters of LV remodeling and infarct tissue characteristics. HDL=high density lipoprotein,
ECG=electrocardiogram, LVEF=left ventricular ejection fraction, WMSI=wall motion score index, EDV=end-diastolic volume, ESV=end-systolic volume., NA=not applicable. |
